New Delhi: Drug firm Eris Lifesciences on Tuesday reported 4.02 per cent rise in consolidated net profit to Rs 56.05 crore for the quarter ended March 31, 2020.

The company posted a net profit of Rs 53.88 crore for January-March period of 2018-19, Eris Lifesciences said in a filing to BSE.

Revenue from operations stood at Rs 248.56 crore during the quarter under review as against Rs 214.82 crore in the year-ago period, it added.

In 2019-20, the net profit of the company stood at Rs 296.29 crore as against Rs 291.14 crore a year ago, the filing said.

Revenue from operations in the last financial year was Rs 1,074.05 crore . It was Rs 982.16 crore in 2018-19, it added.

Shares of Eris Lifesciences were trading at Rs 529.10 apiece on BSE, up 0.17 per cent from the previous close.

if(geolocation && geolocation != 5 && (typeof skip == ‘undefined’ || typeof skip.fbevents == ‘undefined’)) {
!function(f,b,e,v,n,t,s)
{if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};
if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version=’2.0′;
n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];
s.parentNode.insertBefore(t,s)}(window, document,’script’,
‘https://connect.facebook.net/en_US/fbevents.js’);
fbq(‘init’, ‘338698809636220’);
fbq(‘track’, ‘PageView’);
}

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here